Globus Medical, Inc. (GMED)
69.27
+0.67
(+0.98%)
USD |
NYSE |
Nov 20, 10:10
Globus Medical Cash from Operations (Quarterly) : 265.23M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 265.23M |
| June 30, 2026 | 209.74M |
| March 31, 2026 | 202.36M |
| December 31, 2025 | 248.59M |
| September 30, 2025 | 249.70M |
| June 30, 2025 | 77.86M |
| March 31, 2025 | 177.30M |
| December 31, 2024 | 210.34M |
| September 30, 2024 | 203.65M |
| June 30, 2024 | 54.26M |
| March 31, 2024 | 52.39M |
| December 31, 2023 | 104.67M |
| September 30, 2023 | 50.48M |
| June 30, 2023 | 35.03M |
| March 31, 2023 | 53.31M |
| December 31, 2022 | 63.98M |
| September 30, 2022 | 32.92M |
| June 30, 2022 | 36.88M |
| March 31, 2022 | 44.69M |
| December 31, 2021 | 76.25M |
| September 30, 2021 | 77.26M |
| June 30, 2021 | 59.19M |
| March 31, 2021 | 63.57M |
| December 31, 2020 | 80.18M |
| September 30, 2020 | 53.25M |
| Date | Value |
|---|---|
| June 30, 2020 | 23.07M |
| March 31, 2020 | 42.29M |
| December 31, 2019 | 54.31M |
| September 30, 2019 | 55.87M |
| June 30, 2019 | 22.60M |
| March 31, 2019 | 39.20M |
| December 31, 2018 | 44.29M |
| September 30, 2018 | 51.79M |
| June 30, 2018 | 33.27M |
| March 31, 2018 | 52.30M |
| December 31, 2017 | 44.84M |
| September 30, 2017 | 34.80M |
| June 30, 2017 | 25.98M |
| March 31, 2017 | 53.45M |
| December 31, 2016 | 51.90M |
| September 30, 2016 | 31.18M |
| June 30, 2016 | 23.80M |
| March 31, 2016 | 39.38M |
| December 31, 2015 | 44.81M |
| September 30, 2015 | 30.75M |
| June 30, 2015 | 14.47M |
| March 31, 2015 | 34.67M |
| December 31, 2014 | 25.32M |
| September 30, 2014 | 35.64M |
| June 30, 2014 | 12.35M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 1.737B |
| Becton, Dickinson & Co. | 1.458B |
| Merit Medical Systems, Inc. | 65.27M |
| Teleflex, Inc. | 147.76M |
| Glaukos Corp. | 38.57M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -155.90M |
| Cash from Financing (Quarterly) | -130.76M |
| Free Cash Flow | 766.47M |
| Free Cash Flow Per Share (Quarterly) | 1.653 |
| Free Cash Flow to Equity (Quarterly) | 228.56M |
| Free Cash Flow to Firm (Quarterly) | 224.84M |
| Free Cash Flow Yield | 8.34% |